BUZZ-IDEXX Labs rises on quarterly results beat

Shares of animal diagnostics maker IDEXX Laboratories IDXX.O rise 8.5% to $458 premarket

IDXX posts Q4 rev. of $954.3 mln, above analysts' est. of $935 mln, according to data compiled by LSEG, driven by strong demand for its veterinary diagnostic services despite persistent weakness in visits to the vet clinic

IDXX posts Q4 adj. EPS of $2.62/shr, above analysts' est. of $2.40/shr - LSEG

IDXX forecasts 2025 rev. between $4.06 bln and $4.17 bln, the midpoint of which is slightly below analysts' estimates of $4.14 bln

IDXX forecasts 2025 EPS to be between $11.74 and $12.24 per share vs. analysts' est. of $11.92 per share

IDXXn fell ~25% in 2024